Skip to main content
Caplight Logo









Drugstore Nigeria

Drugstore Nigeria

Private
IkoroduConsumer & Commercehttps://drugstore.ng/

Last Round

Grant

Sep 18, 2023

Total Funding Raised

$75,000

Company Overview

Drugstore Nigeria is a health tech company that operates an online pharmacy marketplace connecting consumers with registered pharmacies in Nigeria.

Sector

Consumer & Commerce

Verticals

E-commerce, Pharma Supply Chain, Telemedicine, Last-Mile Delivery, Mobile Commerce

Business Model

B2B2C

Customer Profile

Marketplace Commission

AI Layer

Non-AI

Keywords

online pharmacypharmacy marketplacee-pharmacydigital pharmacydrug deliverypharmacy aggregatormedication deliverytelepharmacyonline pharmacist consultationprescription refillspharma supply chainlast-mile deliverymedical suppliesB2B2C marketplacehospital equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Drugstore Nigeria Comparables

Compare Drugstore Nigeria with similar companies based on industry and business-model similarity.

Drugstore Nigeria comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GoMed Nigeria
89%
OneHealth
86%
Pharmarun
85%

Drugstore Nigeria Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 18, 2023
AcceleratorJun 30, 2021

Key People

Founding team and executive leadership

Yemi Olutoye

CEO and Co-Founder at Drugstore.ng, Head of Product, Founder

Founding Team

Drugstore Nigeria Investors

Notable investors and investment history

Drugstore Nigeria investors
InvestorRounds
Bill & Melinda Gates FoundationGrant
The Baobab NetworkAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 5, 2026

    Monthly visitors increased 34% MoM, reaching 32.3K.

  • Mar 21, 2025

    Grew 15% QoQ, from 33 to 38 employees.

Drugstore Nigeria Filings

Explore SEC and related filing metadata, where available.

Drugstore Nigeria filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Drugstore Nigeria's valuation, stock price, and market status.

Is Drugstore Nigeria a public or private company?

Drugstore Nigeria is a private company.

What is the current stock price of Drugstore Nigeria?

Drugstore Nigeria is a private company, so its shares have no public market price. Caplight tracks Drugstore Nigeria's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Drugstore Nigeria worth (valuation)?

Valuation information for Drugstore Nigeria is not publicly available.

Can I buy Drugstore Nigeria stock?

Drugstore Nigeria shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Drugstore Nigeria's last funding round?

Drugstore Nigeria's most recent funding round was Grant on September 18, 2023.

Who are the main investors in Drugstore Nigeria?

Key investors in Drugstore Nigeria include Bill & Melinda Gates Foundation, The Baobab Network.

Will Drugstore Nigeria IPO soon?

No public IPO plans have been announced for Drugstore Nigeria.

How can I track Drugstore Nigeria secondary market activity?

Caplight tracks bids, offers, and trades in Drugstore Nigeria's shares on secondary markets.

Firmographic Details

HeadquartersIkorodu
Employee Range15
Year Founded2017
Last FundingSep 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?